West Oak Capital, LLC - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 726 filers reported holding GLAXOSMITHKLINE PLC in Q4 2015. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.

Quarter-by-quarter ownership
West Oak Capital, LLC ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q3 2017$4,466,000
-5.8%
1100.0%0.00%0.0%
Q2 2017$4,743,000
+2.3%
1100.0%0.00%0.0%
Q1 2017$4,638,000
+9.5%
1100.0%0.00%0.0%
Q4 2016$4,236,000
-58.2%
110
-53.2%
0.00%
-57.1%
Q3 2016$10,136,000
+112.6%
235
+113.6%
0.01%
+133.3%
Q2 2016$4,767,000
+6.9%
1100.0%0.00%0.0%
Q1 2016$4,461,000
+0.5%
1100.0%0.00%0.0%
Q4 2015$4,439,000
+4.9%
1100.0%0.00%0.0%
Q3 2015$4,230,000
-7.7%
1100.0%0.00%0.0%
Q2 2015$4,582,000
-9.7%
1100.0%0.00%
-25.0%
Q1 2015$5,077,000
-82.3%
110
-83.6%
0.00%
-81.0%
Q4 2014$28,679,000
+467.1%
671
+510.0%
0.02%
+425.0%
Q3 2014$5,057,000
-14.0%
1100.0%0.00%0.0%
Q2 2014$5,883,000
+0.1%
1100.0%0.00%0.0%
Q1 2014$5,877,000
+0.1%
1100.0%0.00%0.0%
Q4 2013$5,873,000
+6.4%
1100.0%0.00%0.0%
Q3 2013$5,519,000
+0.4%
1100.0%0.00%
-20.0%
Q2 2013$5,497,0001100.01%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q4 2015
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 100,000$3,680,00012.40%
Black Creek Investment Management Inc. 7,443,061$273,905,0008.54%
KAHN BROTHERS GROUP INC 1,281,924$47,174,803,0008.23%
Camber Capital Management LP 3,500,000$128,800,0004.52%
Eversept Partners, LP 946,581$35,196,5224.13%
EQUITY INVESTMENT CORP 2,321,164$85,419,0003.98%
Galibier Capital Management Ltd. 575,741$21,187,0003.66%
Keystone Financial Planning, Inc. 217,399$8,000,0003.32%
CLIFFORD CAPITAL PARTNERS LLC 217,817$8,016,0003.14%
CLARK ESTATES INC/NY 485,000$17,848,0002.52%
View complete list of GLAXOSMITHKLINE PLC shareholders